Filing Details
- Accession Number:
- 0001209191-11-013634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-01 15:06:58
- Reporting Period:
- 2011-02-25
- Filing Date:
- 2011-03-01
- Accepted Time:
- 2011-03-01 15:06:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1446847 | Ironwood Pharmaceuticals Inc | IRWD | Pharmaceutical Preparations (2834) | 043404176 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1478244 | G Mark Currie | C/O Ironwood Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Acquisiton | 2011-02-25 | 379 | $0.60 | 210,379 | No | 4 | M | Direct | |
| Class B Common Stock | Disposition | 2011-02-25 | 379 | $12.50 | 210,000 | No | 4 | S | Direct | |
| Class B Common Stock | Acquisiton | 2011-02-28 | 1,900 | $0.60 | 211,900 | No | 4 | M | Direct | |
| Class B Common Stock | Disposition | 2011-02-28 | 1,900 | $12.50 | 210,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class B Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-25 | 379 | $0.00 | 379 | $0.60 |
| Class B Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2011-02-28 | 1,900 | $0.00 | 1,900 | $0.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 109,621 | 2012-09-24 | No | 4 | M | Direct | |
| 107,721 | 2012-09-24 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
- The option vested as to 25% of the shares of Class B Common Stock on the first anniversary of August 22, 2002, and 1/48th of the shares of Class B Common Stock vested each month thereafter for the next 36 months. The option was fully vested as of August 22, 2006.
Billionaire Hedge Funds
